IFNG and sarcoma: No association was observed between CSF3R, neutrophil signature, IFNG, or type 1 immune signature and outcome in other sarcomas (i.e., dedifferentiated liposarcoma, leiomyosarcoma and myxofibrosarcoma) (Figures S7B–S7M).